Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Science Translational Medicine

• Publication date

  2011-11-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.3002878PMID 22049067PMCID PMC3501269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune defence against EBV and EBV-associated disease.

  2011cited by this paper
• Epstein‐Barr virus and gastric carcinoma

  2010cited by this paper
• HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

  2010cited by this paper
• A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

  2009cited by this paper
• Recombinant gp 350 Vaccine for Infectious Mononucleosis : A Phase 2 , Randomized , Double-Blind , Placebo-Controlled Trial to Evaluate the Safety , Immunogenicity , and Efficacy of an Epstein-Barr Virus Vaccine in Healthy Young Adults

  2007cited by this paper
• Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

  2007cited by this paper
• Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

  2007cited by this paper
• The global health burden of infection‐associated cancers in the year 2002

  2006cited by this paper
• Epstein-Barr virus infection.

  2000cited by this paper
• The Fred Hutchinson Cancer Research Center

  1998cited by this paper
• Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccine

  1985cited by this paper

• Brusatol enhances ferroptosis susceptibility in nasopharyngeal carcinoma by downregulating Nrf2 expression.

  2026cites this paper
• Lamin A/C maintains genome topology and regulates transcriptional programs essential for virus-driven B cell activation

  2026cites this paper
• The EBV-MS paradigm: beyond molecular mimicry toward new therapeutic strategies.

  2026cites this paper
• Expanding the Global Landscape of Epstein–Barr Virus Genomes: A Call for Greater Representation

  2026cites this paper
• A tonsil organoid model reveals Epstein-Barr virus infected germinal center B cell states during primary infection

  2026cites this paper
• Interaction between HIV-1 Tat and EBV Zta favours immune escape of B cells by downregulating HLA-ABC expression

  2026cites this paper
• Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs

  2026cites this paper
• Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines

  2025cites this paper
• Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications

  2025cites this paper
• Epstein-Barr virus-infected tonsillar marginal zone B cells in vivo as a precursor for immunosuppression-related B-cell lymphoma

  2025cites this paper
• Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation

  2025cites this paper
• EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation

  2025cites this paper
• Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350.

  2025cites this paper
• Epstein–Barr Virus Hijacks Redox Signaling via Glutathione Peroxidase 4 to Sustain Latency and Drive Gastric Cancer Progression

  2025cites this paper
• Prophylactic and Therapeutic EBV Vaccination.

  2025cites this paper
• The CXCL10‐CXCR3 Axis Induces Tumor‐Associated Neutrophils to Interfere with CTLs‐Mediated Antitumor Activity in EBV‐Associated Epithelial Cancers

  2025cites this paper
• Gastrointestinal inflammation and cancer: viral and bacterial interplay

  2025cites this paper
• Infectious Mononucleosis.

  2025cites this paper
• Mechanisms of Viral Oncogenesis: DNA and RNA Viruses in Human Cancer

  2025cites this paper
• The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virus

  2025cites this paper
• Beyond immortality: Epstein-Barr virus and the intricate dance of programmed cell death in cancer development.

  2025cites this paper
• Multiple sclerosis and infection: history, EBV, and the search for mechanism

  2025cites this paper
• Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization

  2025cites this paper
• Cytomegalovirus and Epstein-Barr virus infections among Jordanians: seroprevalence and associated factors

  2025cites this paper
• Epstein-Barr Virus-Driven B-Cell Transformation under Germinal Center Hypoxia Requires External Unsaturated Fatty Acids

  2025cites this paper
• A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection

  2025cites this paper
• Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor

  2025cites this paper
• Epstein-Barr virus-transformed B-cells from a hypoxia model of the germinal center requires external unsaturated fatty acids

  2025cites this paper
• A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection

  2025cites this paper
• Applying principles of vaccine development to oncomicrobial vaccines

  2025cites this paper
• Hip metastasis presenting as anterior knee pain from nasopharyngeal carcinoma: A case report

  2025cites this paper
• EBV‐Positive Diffuse Large B‐Cell Lymphoma (DLBCL): An Assessment and a Roadmap

  2025cites this paper
• Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation

  2025cites this paper
• Early multiple sclerosis activity associated with TBX21+CD21loCXCR3+ B cell expansion resembling EBV-induced phenotypes

  2025cites this paper
• In-Silico Study on the Role of Epstein Barr Virus to translocate Tobacco Constituents into blood to lead to Oral Cancer

  2025cites this paper
• Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery

  2024cites this paper
• Multiple cross displacement amplification combined with nanoparticle-based lateral flow biosensor for rapid and sensitive detection of Epstein-Barr virus

  2024cites this paper
• Si algo puede fallar, fallará: el virus Epstein-Barr y su contención inmunitaria

  2024cites this paper
• EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma

  2024cites this paper
• Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial

  2024cites this paper
• Appraising the life-course impact of Epstein-Barr virus exposure and its genetic signature on periodontitis.

  2024cites this paper
• Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

  2024cites this paper
• Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma

  2024cites this paper
• Epstein-Barr-Virus-Driven Cardiolipin Synthesis Sustains Metabolic Remodeling During B-cell Lymphomagenesis

  2024cites this paper
• EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment

  2024cites this paper
• An insect cell-derived extracellular vesicle-based gB vaccine elicits robust adaptive immune responses against Epstein-Barr virus

  2024cites this paper
• The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verification

  2024cites this paper
• Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation

  2024cites this paper
• The Impact of Acute EBV Infection on Changes in the Serum Proteome in Children—A Pilot Study

  2024cites this paper
• KSHV infection of B cells primes protective T cell responses in humanized mice

  2024cites this paper
• Landscape of Epstein-Barr virus gene expression and perturbations in cancer

  2024cites this paper
• Montmorillonite nanosheets as an adjuvant eliciting potent cellular immunity

  2024cites this paper
• [Anything that can go wrong: cytotoxic cells and their control of Epstein-Barr virus].

  2024cites this paper
• Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment

  2024cites this paper
• STINGing Defenses: Unmasking the Mechanisms of DNA Oncovirus-Mediated Immune Escape

  2024cites this paper
• Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.

  2024cites this paper
• Epigenetics of Epstein Barr virus - A review.

  2023cites this paper
• Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes

  2023cites this paper
• Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma

  2023cites this paper
• A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China

  2023cites this paper
• The hide-and-seek game of the oncogenic epstein-barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale.

  2023cites this paper
• Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancer

  2023cites this paper
• Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice

  2023cites this paper
• Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

  2023cites this paper
• Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release

  2023cites this paper
• Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events

  2023cites this paper
• Epstein‒Barr virus-associated cellular immunotherapy.

  2023cites this paper
• Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma

  2023cites this paper
• Expression and Significance of Epstein-Barr Virus-Latent Membrane Protein 1 in Acquired Immune Deficiency Syndrome-Related Diffuse Large B-Cell Lymphoma

  2023cites this paper
• Prospects for using CRISPR-Cas9 system in the treatment of human viral diseases

  2023cites this paper
• A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth

  2023cites this paper
• The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies

  2023cites this paper
• Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody.

  2023cites this paper
• The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities

  2023cites this paper
• An update on genetic aberrations in T-cell neoplasms.

  2023cites this paper
• Diagnostic Value of Whole-Blood and Plasma Samples in Epstein–Barr Virus Infections

  2023influential citation
• Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model

  2023cites this paper
• Metaproteomic Analysis of an Oral Squamous Cell Carcinoma Dataset Suggests Diagnostic Potential of the Mycobiome

  2023cites this paper
• Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

  2023cites this paper
• Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study

  2023cites this paper
• An EBV-associated atypical B cell signature in clinically isolated syndrome is implicated in progression of multiple sclerosis

  2023cites this paper
• Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1

  2023cites this paper
• A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection

  2023cites this paper
• Ferritin-based nanomedicine for disease treatment

  2023cites this paper
• LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells

  2023cites this paper
• Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis

  2023cites this paper
• Malignancy and viral infections in Sub-Saharan Africa: A review

  2023cites this paper
• mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice

  2023cites this paper
• A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma

  2022cites this paper
• Does delayed EBV infection contribute to rising childhood cancers?

  2022cites this paper
• mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches

  2022cites this paper
• Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro

  2022cites this paper
• The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines

  2022cites this paper
• Serological profiling using an Epstein-Barr virus mammalian expression library identifies EBNA1 IgA as a pre-diagnostic marker for nasopharyngeal carcinoma.

  2022cites this paper
• EBV-associated diseases: Current therapeutics and emerging technologies

  2022cites this paper
• How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection

  2022cites this paper
• Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection.

  2022cites this paper
• Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion

  2022cites this paper
• The nuclear egress complex of Epstein-Barr virus buds membranes through an oligomerization-driven mechanism

  2022cites this paper
• Epstein-Barr-Virus-assoziierte Erkrankungen bei Kindern und Jugendlichen

  2022cites this paper